Target therapy in metastatic pheochromocytoma: current perspectives and controversies
Most of the pheochromocytomas (PCCs) are benign neoplasms, but when they are malignant, they can be difficult to treat. Despite advances in diagnosis and imaging, it remains an untreatable tumor, when metastases develop. A deeper understanding of the alteration of the specific molecular pathways cau...
Saved in:
Main Authors: | Amrallah A. Mohammed (Author), Ayman M. El-Shentenawy (Author), Mohamed A. Sherisher (Author), Hani M. El-Khatib (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hormonal therapy in metastatic prostate cancer: current perspectives and controversies
by: Manish Garg, et al.
Published: (2013) -
Urinary bladder cancer: biomarkers and target therapy, new era for more attention
by: Amrallah A. Mohammed, et al.
Published: (2016) -
Pheochromocytoma resection: Current concepts in anesthetic management
by: Harish Ramakrishna
Published: (2015) -
Bilateral and metastatic pheochromocytoma in a 11-year-old child: A case report
by: Takwa Mili, et al.
Published: (2023) -
Current Controversies in Newer Therapies to Treat Birth Asphyxia
by: Pia Wintermark
Published: (2011)